“Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC” (2025) Radiology and Oncology, 59(4), pp. 624–634. Available at: https://www.radioloncol.com/index.php/ro/article/view/4685 (Accessed: 1 October 2026).